Loading…

CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study

Summary Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T‐cell populations associated with immunosenescenc...

Full description

Saved in:
Bibliographic Details
Published in:Aging cell 2016-04, Vol.15 (2), p.389-392
Main Authors: Spyridopoulos, Ioakim, Martin‐Ruiz, Carmen, Hilkens, Catharien, Yadegarfar, Mohammad E., Isaacs, John, Jagger, Carol, Kirkwood, Tom, Zglinicki, Thomas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53
cites cdi_FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53
container_end_page 392
container_issue 2
container_start_page 389
container_title Aging cell
container_volume 15
creator Spyridopoulos, Ioakim
Martin‐Ruiz, Carmen
Hilkens, Catharien
Yadegarfar, Mohammad E.
Isaacs, John
Jagger, Carol
Kirkwood, Tom
Zglinicki, Thomas
description Summary Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T‐cell populations associated with immunosenescence were informative for adverse cardiovascular outcome in the very old, we prospectively analyzed peripheral blood samples from 751 octogenarians (38% males) from the Newcastle 85+ study for their power to predict survival during a 65‐month follow‐up (47.3% survival rate). CMV‐seropositive participants showed a higher prevalence of CHD (37.7% vs. 26.7%, P = 0.030) compared to CMV‐seronegative participants together with lower CD4/CD8 ratio (1.7 vs. 4.1, P 
doi_str_mv 10.1111/acel.12430
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4783336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A705799341</galeid><sourcerecordid>A705799341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53</originalsourceid><addsrcrecordid>eNqNks9uEzEQxlcIREvhwgMgS1wQVYL_7K7XHJCiqBSkAJfC1XLs2dTVrp3a3lS58QAceEaepN6mBIoQwj7Y8vzm88ynKYqnBE9JXq-Uhm5KaMnwveKQlLycCE7r-_s7aQ6KRzFeYEy4wOxhcUDrWtSM0sPi2_zDFxQh-LWPNtmNTVuknEFnP75-z7JdjjmIGpwGtA5grE7IOh1ARTBIq2Cs36ioh04F1PuQVDdKWIe8Tn4FTgWrXHyNAsShSxG1wfconQP6CFdaxdQBaqpjFNNgto-LB63qIjy5PY-Kz29PzubvJotPp-_ns8VE16TBE14KkltRAFwL3hhjCNfLmpW0UTjHWkEFgKBaLw1rKwE1YMCKVJo3Ga_YUfFmp7selj2Y3F0KqpPrYHsVttIrK-9GnD2XK7-RJW8YY3UWeHErEPzlADHJ3sbRLuXAD1ES3lSUUcLpf6CckrLMxWf0-R_ohR-Cy06MFGGkJhX5Ra1UB9K61ucS9SgqZxxXXAhWjtT0L1TeBnqrvYPW5vc7CS93CTr4GAO0ezsIluOYyXHM5M2YZfjZ7wbu0Z9zlQGyA67yN9t_SMnZ_GSxE70GlL3e4Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1771316151</pqid></control><display><type>article</type><title>CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Spyridopoulos, Ioakim ; Martin‐Ruiz, Carmen ; Hilkens, Catharien ; Yadegarfar, Mohammad E. ; Isaacs, John ; Jagger, Carol ; Kirkwood, Tom ; Zglinicki, Thomas</creator><creatorcontrib>Spyridopoulos, Ioakim ; Martin‐Ruiz, Carmen ; Hilkens, Catharien ; Yadegarfar, Mohammad E. ; Isaacs, John ; Jagger, Carol ; Kirkwood, Tom ; Zglinicki, Thomas</creatorcontrib><description>Summary Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T‐cell populations associated with immunosenescence were informative for adverse cardiovascular outcome in the very old, we prospectively analyzed peripheral blood samples from 751 octogenarians (38% males) from the Newcastle 85+ study for their power to predict survival during a 65‐month follow‐up (47.3% survival rate). CMV‐seropositive participants showed a higher prevalence of CHD (37.7% vs. 26.7%, P = 0.030) compared to CMV‐seronegative participants together with lower CD4/CD8 ratio (1.7 vs. 4.1, P &lt; 0.0001) and higher frequencies of senescence‐like CD4 memory cells (41.1% vs. 4.5%, P &lt; 0.001) and senescence‐like CD8 memory cells (TEMRA, 28.1% vs. 6.7%, P &lt; 0.001). CMV seropositivity was also associated with increased six‐year cardiovascular mortality (HR 1.75 [1.09–2.82], P = 0.021) or death from myocardial infarction and stroke (HR 1.89 [107–3.36], P = 0.029). Gender‐adjusted multivariate Cox regression analysis revealed that low percentages of senescence‐like CD4 T cells (HR 0.48 [0.32–0.72], P &lt; 0.001) and near‐senescent (CD27 negative) CD8 T cells (HR 0.60 [0.41–0.88], P = 0.029) reduced the risk of cardiovascular death. For senescence‐like CD4, but not near‐senescent CD8 T cells, these associations remained robust after additional adjustment for CMV status, comorbidities, and inflammation markers. We conclude that CMV seropositivity is linked to a higher incidence of CHD in octogenarians and that senescence in both the CD4 and CD8 T‐cell compartments is a predictor of overall cardiovascular mortality as well as death from myocardial infarction and stroke.</description><identifier>ISSN: 1474-9718</identifier><identifier>EISSN: 1474-9726</identifier><identifier>DOI: 10.1111/acel.12430</identifier><identifier>PMID: 26696322</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Age Factors ; Aged, 80 and over ; aging ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - immunology ; Cardiovascular Diseases - microbiology ; Cardiovascular Diseases - mortality ; CD4 ; CD8 ; Chronic Disease - mortality ; Comparative analysis ; Coronary heart disease ; Cytomegalovirus ; Cytomegalovirus infections ; Cytomegalovirus Infections - blood ; Cytomegalovirus Infections - immunology ; Cytomegalovirus Infections - mortality ; Cytomegalovirus Infections - pathology ; Female ; Humans ; immunosenescence ; Male ; Memory (Computers) ; Mortality ; octogenarians ; Patient outcomes ; Prognosis ; Short Take ; survival ; T cells ; T lymphocytes ; T-Lymphocytes - immunology ; T-Lymphocytes - pathology ; United Kingdom - epidemiology</subject><ispartof>Aging cell, 2016-04, Vol.15 (2), p.389-392</ispartof><rights>2015 The Authors. published by the Anatomical Society and John Wiley &amp; Sons Ltd.</rights><rights>2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley &amp; Sons Ltd.</rights><rights>COPYRIGHT 2015 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2016 The Anatomical Society and John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53</citedby><cites>FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783336/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1771316151?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26696322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spyridopoulos, Ioakim</creatorcontrib><creatorcontrib>Martin‐Ruiz, Carmen</creatorcontrib><creatorcontrib>Hilkens, Catharien</creatorcontrib><creatorcontrib>Yadegarfar, Mohammad E.</creatorcontrib><creatorcontrib>Isaacs, John</creatorcontrib><creatorcontrib>Jagger, Carol</creatorcontrib><creatorcontrib>Kirkwood, Tom</creatorcontrib><creatorcontrib>Zglinicki, Thomas</creatorcontrib><title>CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study</title><title>Aging cell</title><addtitle>Aging Cell</addtitle><description>Summary Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T‐cell populations associated with immunosenescence were informative for adverse cardiovascular outcome in the very old, we prospectively analyzed peripheral blood samples from 751 octogenarians (38% males) from the Newcastle 85+ study for their power to predict survival during a 65‐month follow‐up (47.3% survival rate). CMV‐seropositive participants showed a higher prevalence of CHD (37.7% vs. 26.7%, P = 0.030) compared to CMV‐seronegative participants together with lower CD4/CD8 ratio (1.7 vs. 4.1, P &lt; 0.0001) and higher frequencies of senescence‐like CD4 memory cells (41.1% vs. 4.5%, P &lt; 0.001) and senescence‐like CD8 memory cells (TEMRA, 28.1% vs. 6.7%, P &lt; 0.001). CMV seropositivity was also associated with increased six‐year cardiovascular mortality (HR 1.75 [1.09–2.82], P = 0.021) or death from myocardial infarction and stroke (HR 1.89 [107–3.36], P = 0.029). Gender‐adjusted multivariate Cox regression analysis revealed that low percentages of senescence‐like CD4 T cells (HR 0.48 [0.32–0.72], P &lt; 0.001) and near‐senescent (CD27 negative) CD8 T cells (HR 0.60 [0.41–0.88], P = 0.029) reduced the risk of cardiovascular death. For senescence‐like CD4, but not near‐senescent CD8 T cells, these associations remained robust after additional adjustment for CMV status, comorbidities, and inflammation markers. We conclude that CMV seropositivity is linked to a higher incidence of CHD in octogenarians and that senescence in both the CD4 and CD8 T‐cell compartments is a predictor of overall cardiovascular mortality as well as death from myocardial infarction and stroke.</description><subject>Age Factors</subject><subject>Aged, 80 and over</subject><subject>aging</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - immunology</subject><subject>Cardiovascular Diseases - microbiology</subject><subject>Cardiovascular Diseases - mortality</subject><subject>CD4</subject><subject>CD8</subject><subject>Chronic Disease - mortality</subject><subject>Comparative analysis</subject><subject>Coronary heart disease</subject><subject>Cytomegalovirus</subject><subject>Cytomegalovirus infections</subject><subject>Cytomegalovirus Infections - blood</subject><subject>Cytomegalovirus Infections - immunology</subject><subject>Cytomegalovirus Infections - mortality</subject><subject>Cytomegalovirus Infections - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>immunosenescence</subject><subject>Male</subject><subject>Memory (Computers)</subject><subject>Mortality</subject><subject>octogenarians</subject><subject>Patient outcomes</subject><subject>Prognosis</subject><subject>Short Take</subject><subject>survival</subject><subject>T cells</subject><subject>T lymphocytes</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - pathology</subject><subject>United Kingdom - epidemiology</subject><issn>1474-9718</issn><issn>1474-9726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNqNks9uEzEQxlcIREvhwgMgS1wQVYL_7K7XHJCiqBSkAJfC1XLs2dTVrp3a3lS58QAceEaepN6mBIoQwj7Y8vzm88ynKYqnBE9JXq-Uhm5KaMnwveKQlLycCE7r-_s7aQ6KRzFeYEy4wOxhcUDrWtSM0sPi2_zDFxQh-LWPNtmNTVuknEFnP75-z7JdjjmIGpwGtA5grE7IOh1ARTBIq2Cs36ioh04F1PuQVDdKWIe8Tn4FTgWrXHyNAsShSxG1wfconQP6CFdaxdQBaqpjFNNgto-LB63qIjy5PY-Kz29PzubvJotPp-_ns8VE16TBE14KkltRAFwL3hhjCNfLmpW0UTjHWkEFgKBaLw1rKwE1YMCKVJo3Ga_YUfFmp7selj2Y3F0KqpPrYHsVttIrK-9GnD2XK7-RJW8YY3UWeHErEPzlADHJ3sbRLuXAD1ES3lSUUcLpf6CckrLMxWf0-R_ohR-Cy06MFGGkJhX5Ra1UB9K61ucS9SgqZxxXXAhWjtT0L1TeBnqrvYPW5vc7CS93CTr4GAO0ezsIluOYyXHM5M2YZfjZ7wbu0Z9zlQGyA67yN9t_SMnZ_GSxE70GlL3e4Q</recordid><startdate>201604</startdate><enddate>201604</enddate><creator>Spyridopoulos, Ioakim</creator><creator>Martin‐Ruiz, Carmen</creator><creator>Hilkens, Catharien</creator><creator>Yadegarfar, Mohammad E.</creator><creator>Isaacs, John</creator><creator>Jagger, Carol</creator><creator>Kirkwood, Tom</creator><creator>Zglinicki, Thomas</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>201604</creationdate><title>CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study</title><author>Spyridopoulos, Ioakim ; Martin‐Ruiz, Carmen ; Hilkens, Catharien ; Yadegarfar, Mohammad E. ; Isaacs, John ; Jagger, Carol ; Kirkwood, Tom ; Zglinicki, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Age Factors</topic><topic>Aged, 80 and over</topic><topic>aging</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - immunology</topic><topic>Cardiovascular Diseases - microbiology</topic><topic>Cardiovascular Diseases - mortality</topic><topic>CD4</topic><topic>CD8</topic><topic>Chronic Disease - mortality</topic><topic>Comparative analysis</topic><topic>Coronary heart disease</topic><topic>Cytomegalovirus</topic><topic>Cytomegalovirus infections</topic><topic>Cytomegalovirus Infections - blood</topic><topic>Cytomegalovirus Infections - immunology</topic><topic>Cytomegalovirus Infections - mortality</topic><topic>Cytomegalovirus Infections - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>immunosenescence</topic><topic>Male</topic><topic>Memory (Computers)</topic><topic>Mortality</topic><topic>octogenarians</topic><topic>Patient outcomes</topic><topic>Prognosis</topic><topic>Short Take</topic><topic>survival</topic><topic>T cells</topic><topic>T lymphocytes</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - pathology</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spyridopoulos, Ioakim</creatorcontrib><creatorcontrib>Martin‐Ruiz, Carmen</creatorcontrib><creatorcontrib>Hilkens, Catharien</creatorcontrib><creatorcontrib>Yadegarfar, Mohammad E.</creatorcontrib><creatorcontrib>Isaacs, John</creatorcontrib><creatorcontrib>Jagger, Carol</creatorcontrib><creatorcontrib>Kirkwood, Tom</creatorcontrib><creatorcontrib>Zglinicki, Thomas</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spyridopoulos, Ioakim</au><au>Martin‐Ruiz, Carmen</au><au>Hilkens, Catharien</au><au>Yadegarfar, Mohammad E.</au><au>Isaacs, John</au><au>Jagger, Carol</au><au>Kirkwood, Tom</au><au>Zglinicki, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study</atitle><jtitle>Aging cell</jtitle><addtitle>Aging Cell</addtitle><date>2016-04</date><risdate>2016</risdate><volume>15</volume><issue>2</issue><spage>389</spage><epage>392</epage><pages>389-392</pages><issn>1474-9718</issn><eissn>1474-9726</eissn><abstract>Summary Although chronic infection with cytomegalovirus (CMV) is known to drive T lymphocytes toward a senescent phenotype, it remains controversial whether and how CMV can cause coronary heart disease (CHD). To explore whether CMV seropositivity or T‐cell populations associated with immunosenescence were informative for adverse cardiovascular outcome in the very old, we prospectively analyzed peripheral blood samples from 751 octogenarians (38% males) from the Newcastle 85+ study for their power to predict survival during a 65‐month follow‐up (47.3% survival rate). CMV‐seropositive participants showed a higher prevalence of CHD (37.7% vs. 26.7%, P = 0.030) compared to CMV‐seronegative participants together with lower CD4/CD8 ratio (1.7 vs. 4.1, P &lt; 0.0001) and higher frequencies of senescence‐like CD4 memory cells (41.1% vs. 4.5%, P &lt; 0.001) and senescence‐like CD8 memory cells (TEMRA, 28.1% vs. 6.7%, P &lt; 0.001). CMV seropositivity was also associated with increased six‐year cardiovascular mortality (HR 1.75 [1.09–2.82], P = 0.021) or death from myocardial infarction and stroke (HR 1.89 [107–3.36], P = 0.029). Gender‐adjusted multivariate Cox regression analysis revealed that low percentages of senescence‐like CD4 T cells (HR 0.48 [0.32–0.72], P &lt; 0.001) and near‐senescent (CD27 negative) CD8 T cells (HR 0.60 [0.41–0.88], P = 0.029) reduced the risk of cardiovascular death. For senescence‐like CD4, but not near‐senescent CD8 T cells, these associations remained robust after additional adjustment for CMV status, comorbidities, and inflammation markers. We conclude that CMV seropositivity is linked to a higher incidence of CHD in octogenarians and that senescence in both the CD4 and CD8 T‐cell compartments is a predictor of overall cardiovascular mortality as well as death from myocardial infarction and stroke.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>26696322</pmid><doi>10.1111/acel.12430</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1474-9718
ispartof Aging cell, 2016-04, Vol.15 (2), p.389-392
issn 1474-9718
1474-9726
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4783336
source Wiley Online Library Open Access; Publicly Available Content Database; PubMed Central
subjects Age Factors
Aged, 80 and over
aging
Cardiovascular Diseases - blood
Cardiovascular Diseases - immunology
Cardiovascular Diseases - microbiology
Cardiovascular Diseases - mortality
CD4
CD8
Chronic Disease - mortality
Comparative analysis
Coronary heart disease
Cytomegalovirus
Cytomegalovirus infections
Cytomegalovirus Infections - blood
Cytomegalovirus Infections - immunology
Cytomegalovirus Infections - mortality
Cytomegalovirus Infections - pathology
Female
Humans
immunosenescence
Male
Memory (Computers)
Mortality
octogenarians
Patient outcomes
Prognosis
Short Take
survival
T cells
T lymphocytes
T-Lymphocytes - immunology
T-Lymphocytes - pathology
United Kingdom - epidemiology
title CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A28%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CMV%20seropositivity%20and%20T%E2%80%90cell%20senescence%20predict%20increased%20cardiovascular%20mortality%20in%20octogenarians:%20results%20from%20the%20Newcastle%2085+%20study&rft.jtitle=Aging%20cell&rft.au=Spyridopoulos,%20Ioakim&rft.date=2016-04&rft.volume=15&rft.issue=2&rft.spage=389&rft.epage=392&rft.pages=389-392&rft.issn=1474-9718&rft.eissn=1474-9726&rft_id=info:doi/10.1111/acel.12430&rft_dat=%3Cgale_pubme%3EA705799341%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6180-7491017aee7c978ddd17cb63428a0491f929ee92ccbd3f59e6e0e0a15c7878d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1771316151&rft_id=info:pmid/26696322&rft_galeid=A705799341&rfr_iscdi=true